Latest news
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTPR Newswire Expands AEO & GEO Brand Report to Europe, the Middle East, India and Africa - adnkronos.comadnkronos.com · Wed, 29 Jul 2026 07:00:00 GMT